A detailed history of Steward Partners Investment Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 85,122 shares of AMGN stock, worth $22.5 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
85,122
Previous 73,551 15.73%
Holding current value
$22.5 Million
Previous $23 Million 19.35%
% of portfolio
0.26%
Previous 0.25%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $3.58 Million - $3.9 Million
11,571 Added 15.73%
85,122 $27.4 Million
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $461,126 - $560,389
1,755 Added 2.44%
73,551 $23 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $332,592 - $401,480
1,237 Added 1.75%
71,796 $20.4 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $786,788 - $887,591
3,077 Added 4.56%
70,559 $20.3 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $2.51 Million - $3.12 Million
11,496 Added 20.53%
67,482 $18.1 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $33,854 - $40,032
-158 Reduced 0.28%
55,986 $12.4 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $295,107 - $359,686
1,307 Added 2.38%
56,144 $13.6 Million
Q4 2022

Feb 15, 2023

SELL
$229.03 - $291.01 $348,354 - $442,626
-1,521 Reduced 2.7%
54,837 $14.4 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $151,061 - $170,369
673 Added 1.21%
56,358 $12.7 Million
Q2 2022

Aug 04, 2022

SELL
$230.71 - $256.74 $190,105 - $211,553
-824 Reduced 1.46%
55,685 $13.5 Million
Q1 2022

May 02, 2022

BUY
$219.27 - $242.57 $1.35 Million - $1.49 Million
6,159 Added 12.23%
56,509 $13.7 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $105,406 - $120,628
-530 Reduced 1.04%
50,350 $11.3 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.93 Million - $2.27 Million
-9,110 Reduced 15.19%
50,880 $10.8 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $2.34 Million - $2.59 Million
-9,998 Reduced 14.29%
59,990 $14.6 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $1.17 Million - $1.37 Million
5,284 Added 8.17%
69,988 $17.4 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $124,418 - $148,160
575 Added 0.9%
64,704 $14.9 Million
Q3 2020

Oct 30, 2020

BUY
$234.65 - $260.95 $1.25 Million - $1.39 Million
5,332 Added 9.07%
64,129 $16.3 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $4.11 Million - $5.05 Million
20,793 Added 54.71%
58,797 $13.9 Million
Q1 2020

Apr 29, 2020

SELL
$182.24 - $241.7 $273,906 - $363,275
-1,503 Reduced 3.8%
38,004 $7.7 Million
Q4 2019

Jan 17, 2020

BUY
$189.21 - $243.2 $77,765 - $99,955
411 Added 1.05%
39,507 $9.52 Million
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $242,883 - $291,024
1,395 Added 3.7%
39,096 $7.57 Million
Q2 2019

Jul 25, 2019

SELL
$166.7 - $195.41 $77,015 - $90,279
-462 Reduced 1.21%
37,701 $6.95 Million
Q1 2019

Apr 30, 2019

SELL
$180.87 - $203.88 $5,064 - $5,708
-28 Reduced 0.07%
38,163 $7.25 Million
Q4 2018

Jan 15, 2019

BUY
$178.4 - $208.25 $109,002 - $127,240
611 Added 1.63%
38,191 $7.43 Million
Q3 2018

Oct 23, 2018

SELL
$185.29 - $208.89 $104,132 - $117,396
-562 Reduced 1.47%
37,580 $7.79 Million
Q2 2018

Jul 20, 2018

BUY
$166.05 - $186.51 $1.61 Million - $1.81 Million
9,698 Added 34.1%
38,142 $7.04 Million
Q1 2018

Apr 20, 2018

BUY
$169.43 - $198.0 $30,666 - $35,838
181 Added 0.64%
28,444 $4.85 Million
Q4 2017

Jan 19, 2018

BUY
$168.79 - $188.59 $254,535 - $284,393
1,508 Added 5.64%
28,263 $4.92 Million
Q3 2017

Nov 22, 2017

BUY
$167.29 - $191.0 $604,084 - $689,701
3,611 Added 15.6%
26,755 $4.99 Million
Q2 2017

Nov 22, 2017

BUY
N/A
5,262 Added 29.43%
23,144 $3.99 Million
Q1 2017

Nov 22, 2017

BUY
N/A
8,678 Added 94.29%
17,882 $2.93 Million
Q4 2016

Nov 22, 2017

BUY
N/A
9,204
9,204 $1.35 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Steward Partners Investment Advisory, LLC Portfolio

Follow Steward Partners Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.